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Objective: The purpose of this study was to evaluate the results of open repair for ruptured descending thoracic and
thoracoabdominal aortic aneurysm (RDTAA).
Methods: A retrospective review identified 41 consecutive cases of open surgical repair in 40 patients presenting with
nontraumatic, atherosclerotic RDTAA from 1996 to 2006. Patients with traumatic injuries or complicated dissections
were excluded. Patient characteristics and preoperative, intraoperative, and postoperative variables were collected from
the medical record. Univariate and logistic regression were used to identify factors contributing to mortality and
morbidity in these patients.
Results:The operative mortality rate was 26.8% (11/41). All but two deaths occurred within 24 hours of operation; seven
were intraoperative. Overall actuarial survival rates at 1 and 2 years were 53.7% and 47.1%, respectively. For those who
survived to hospital discharge, the respective numbers were 73.3% and 64.4%. Intraoperative hypotension and blood
transfusion requirements were independent predictors of perioperative death. Octogenarians had a mortality rate
equivalent to that of the younger population (25% vs 27.6%; not significant). There was a strong trend toward an
improved outcome in the latter part (2003-2006) compared with the first part (1995-2002; 13.6% vs 42.1%, respectively;
P  .075).
Conclusions:Direct open repair for RDTAA can be achieved with acceptable mortality and morbidity rates even in elderly
patients. Improved outcome can be expected with increased volume and experience. This series should help establish a
reference against which the results of endovascular endeavors and hybrid procedures could be compared. (J Vasc Surg
2007;45:667-76.)Repair of descending thoracic aneurysms (DTA) and tho-
racoabdominal aortic aneurysms (TAAA) continues to present
a significant challenge to the surgeon, with high attendant
rates of morbidity andmortality. Aneurysms that present with
evidence of either free or contained rupture present an even
greater challenge because these patients historically have had
even higher risks of postoperative complications. These emer-
gency casesmay constitute 15% to 20% of all TAAA repairs.1,2
The literature is relatively sparse with respect to the surgical
outcomes, and the published results vary widely. High-vol-
ume single-center experiences have reported operative mor-
tality rates of 15% to 20%, whereas statewide and Nationwide
Inpatient Sample reviews1,3 have noted mortality rates of
approximately 50%.
This studywas conducted to review a contemporary series
of direct surgical repair of ruptured DTA and TAAA (RD-
TAA) in a tertiary referral center to identify prognostic indi-
cators for adverse outcome and to assessmid-termoutcome in
these patients. This has become increasingly important in the
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development of hybrid procedures to treat more complex
aortic pathology.4-9
MATERIALS AND METHODS
A retrospective review of 40 consecutive patients who
underwent 41 repairs of RDTAAbetween July 1995 and June
2006 was performed. All had atherosclerotic aneurysms ex-
cept one patient who presented with a ruptured perivisceral
aneurysm of a visceral patch after previous repair. Excluded
were patients who underwent repair for traumatic aortic dis-
ruptions or complicated acute aortic dissections. Diagnosis of
rupture was made on the basis of preoperative computed
tomography findings and confirmed in all patients by intraop-
erative visualization of bloodoutside the aneurysmwall, either
in the retroperitoneum or mediastinum for a contained rup-
ture or into the abdominal or pleural cavity for a free rupture
in all patients. There were an additional 10 patients during the
study period who did not receive an operation as a result of
either prohibitive medical factors or patient/family refusal.
Operative mortality was defined as death that occurred
within 30days of operationor in-hospital death if later than30
days. Preoperative shockwas defined as systolic bloodpressure
less than 90mmHgor a requirement for preoperative cardio-
pulmonary resuscitation (CPR). Roughly half (n 19) of the
operations were performed in the first 8 years of our experi-
ence and the remaining half in the last 3 years. All the medical
records and available radiographic imaging studies were re-
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with review of themedical records andwith telephone contact
with the patient or family.
Operations were performed by five different surgeons in
the division of vascular surgery at the University of Pittsburgh
Medical Center. Cerebrospinal fluid (CSF) drainage was per-
formed on the basis of surgeon preference and the stability of
the patient. With respect to use of adjunctive techniques for
end-organ protection, the clamp-and-sew technique was used
routinely for type IV aneurysms. For all others, surgical tech-
nique, including the decision to place the patient on left heart
bypass, was determined by the hemodynamic stability of the
patient at presentation. Intercostal arteries were not routinely
reimplanted, except in one case early in our experience, and
every effort was made to preserve those near or at the anasto-
motic site by beveling the anastomoses. All the visible inter-
costals were ligated before the aneurysm was opened, to
minimize backbleeding and spinal cord ischemia. Any
patent vessels were then suture-ligated. Single-lung venti-
lation was used in all patients. Perfusion to the visceral
arteries was not used, although cold perfusion to the renals
was used when the hemodynamics of the patient permitted.
When left heart bypass was instituted, systemic heparin was
used, and flows were adjusted to maintain mean arterial
pressure between 60 and 70 mmHgmeasured via the right
femoral arterial catheter. CSF drainage was maintained to
keep the pressure less than 10 cm H2O for 2 to 4 days after
surgery. Naloxone, when used, was started at the beginning
of the operation at 1 g · kg1 · h1 and continued for 1 or
2 days.10
Continuous variables are summarized as mean SD, and
nominal variables are summarized as counts or percentages.
Intergroup comparisons were performed with Wilcoxon
signed rank tests for continuous variables or Fisher exact test
statistics for nominal variables. Two-year survival rates were
calculated by using Kaplan-Meier statistics, and comparisons
of time-to-event curves were accomplished with log-rank sta-
tistics where appropriate. Multivariable logistic regression was
used to assess demographic, clinical, and procedural factors
independently associated with in-hospital outcomes and in-
cluded death, dialysis, need for tracheostomy, paraplegia, and
paraparesis. Cox proportional hazards methodology was used
to build a model for 2-year mortality. The long-term survival
rates were estimated with the Kaplan-Meier method. This
study was approved by the University of Pittsburgh Institu-
tional Review Board.
RESULTS
The baseline characteristics of the patients in our study are
listed in Table I. The extent of the aneurysms was as follows:
type I in 8 patients, type II in 3, type III in 11, type IV in 13,
and descending thoracic in 6. The time from the onset of
symptoms to operation was less than 6 hours in 10 patients,
between 6 and 24 hours in 13 patients, and more than 24
hours in 16 patients; this information was not available in 2
patients. The mode of transportation at presentation was by
air in 28 cases (68.3%) and by ground transport in 9. Four
patients were inpatients at the time of their ruptures; allpatients were admitted with symptoms consistent with but
had computed tomographic scans that did not demonstrate
rupture. They subsequently all had clinical deterioration
(three with hypotension) and intraoperative findings consis-
tent with rupture. Those patients with a shorter duration from
symptom onset to operative repair weremore likely to present
in shock requiringCPRwith an in-hospitalmortality of 50% vs
amortality of 6.7% (P .05) in those with symptom duration
of greater than 24 hours (Appendix Tables I and II). Other-
wise, the preoperative characteristics and postoperative out-
comes were similar between these groups.
The mean duration of follow-up for those who survived
Table I. Baseline characteristics of patients undergoing
repair of ruptured DTA and TAAA
Variable Data
Age (y) 75.5  6.6
Female 39.0 (16)
White 94.9 (39)
History of COPD 45.0 (18)
History of CVA 15.0 (6)
History of CAD 67.5 (27)
Smoking 38.5 (15)
History of diabetes mellitus 2.5 (1)
Any prior aortic reconstruction 36.6 (15)
Preoperative characteristics
Symptom onset to OR (h)
6 25.6 (10)
6-24 35.9 (14)
24 38.5 (15)
Mean time 44.9  57.5
Preoperative shock 37.5 (15)
Preoperative CPR 17.1 (7)
Aneurysm size and blood chemistry
Mean aneurysm diameter (cm) 8.4  2.3
Free rupture 26.8 (11)
Mycotic 7.3 (3)
Mean BUN (mg/dL) 24.3  10.8
Mean creatinine (mg/dL) 1.4  0.7
Mean hemoglobin (g/dL) 11.7  4.3
Operative characteristics
After 2002 53.7 (22)
OR time (h) 4.4  1.7
OR fluid used 4598  2262
Blood units used 7.8  5.7
Lowest SBP (mm Hg) 72.2  21.7
Intraoperative CPR 21.9 (9)
Sequential clamp use 24.3 (9)
Clamp time (min) 65.1  19.5
Visceral ischemia time (min) 44.3  15.2
Renal ischemia time (min) 43.1  23.9
Renal cold perfusion 37.1 (13)
Renal bypass 28.6 (10)
Intercostal reimplantation 2.9 (1)
Left heart bypass 41.0 (16)
CSF drain 55.0 (22)
Naloxone 22.5 (9)
Data are % (n) or mean  SD.
COPD, Chronic obstructive pulmonary disease; CVA, cerebrovascular acci-
dent; CAD, coronary artery disease; OR, operating room; CPR, cardiopul-
monary resuscitation; BUN, blood urea nitrogen; SBP, systolic blood pres-
sure; CSF, cerebrospinal fluid.to hospital discharge was 28.4  26.6 months (range, 1.4-
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tient died at day 7 after repair. Of the patients surviving to
discharge, only 6 patients were discharged home, whereas 24
were discharged either to a skilled nursing facility or rehabili-
tation center. Four patients required permanent dialysis, one
of whom became a long-term survivor.
The operative mortality rate was 26.8% (11/41). All but
two deaths occurred within 24 hours of operation. The intra-
operative mortality rate was 17% (7/41); 5 of these patients
had received preoperative CPR. Four deaths occurred during
dissection before the graft could even be implanted. Two
other deathswere due tohemorrhagic shock and cardiac arrest
shortly after operation. After 24 hours, one death occurred at
postoperative day 7 and another at day 31, when the family
withdrew support. After hospital discharge, eight additional
patients died within 6 months of discharge; the mortality rate
at 1 year was 46.3%. Two-year survival curves are represented
in Fig 1. The remaining deaths were late deaths, occurring
after at least 1 year of survival. Although the cause of death
could not be determined in two patients, none of the other
deaths was aneurysm related. Factors associated with in-hos-
pital mortality included intraoperative hypotension (P 
.007) and a shorter duration fromsymptomonset to operation
(Table II; P  .04). The presence of chronic obstructive
pulmonary disease, an increased preoperative blood urea
nitrogen, and the presence of type II and III aneurysms
were associated with increased mortality after discharge
from the hospital (Table III; P  .05).
There were 12 octogenarians. Three patients did not
survive to hospital discharge, accounting for an operative
mortality of 25% as compared with 27.6% in those younger
than 80 years (not significant). Three additional patients died
within 4 months of hospital discharge, resulting in a 1-year
mortality rate of 50%. One additional patient died 22 months
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Fig 1. Cumulative survival of patients undergoing sur
dominal aneurysms.later, 1 month before his 90th birthday. The remaining fivesurvivors are alive and well at a mean of 24 months (range,
10-34 months) follow-up. The baseline characteristics and
comorbidities, except for age, did not differ between the
groups. The only differences observed were lower mean he-
moglobin (9.6  1.9 g/dL vs 12.6  4.8 g/dL; P  .005)
and shortermean renal ischemia time (22.423.2minutes vs
49.4  20.7 minutes; P  .02) in those 80 years or older as
compared with the younger cohort. Kaplan-Meier survival
estimates (Fig 2, A) at 1 and 2 years were 50% and 37.5%,
respectively, for octogenarians, whereas the corresponding
figures were 55.2% and 50.6% for the younger patients (P 
.72).
Spinal cord ischemia developed in five (15.6%) of those
who survived the operation for more than 24 hours and
allowed neurologic evaluation: paraplegia in four patients and
paraparesis in one additional patient. The lone patient who
developed paraparesis recovered from itwithout deficits. Para-
plegia was delayed in onset in three of four patients, all cases of
whichwere associatedwith postoperative hypotension.Of the
four patients who developed paraplegia, two had intraopera-
tive CSF drainage, and both had delayed paraplegia develop:
one while the drain was still in place and the other after its
removal. The latter had the drainage reinstituted without
benefit. The remaining two patients with paraplegia did not
have intraoperative CSF drainage. One of these patients expe-
rienced delayed paraplegia and had a lumbar drain placed; no
improvement in neurologic function was achieved. Risk fac-
tors associated with spinal cord ischemia were extent of the
aneurysm, with type II aneurysms having the highest risk for
the development of paraplegia (P  .0001; Table IV), and
increased aortic cross-clamp time (P .03).
Pulmonary failure requiring tracheostomy developed in
35.5% of patients. Controlling for other operative and patient
characteristics, chronic obstructive pulmonary disease (P 
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more than a fivefold risk for prolonged ventilatory support and
progression to tracheostomy (odds ratio, 5.44; P  .036).
The incidence of renal failure necessitating either temporary
(n  3) or permanent (n  4) dialysis was 19.3%. The only
identified predictor was increased baseline creatinine (P .02).
The mortality rate during the first half (19 of 41 cases
from 1995 through 2002) of this series was 42.1%, as com-
pared with 13.6% in the latter half of our experience (22 of 41
cases since 2003). Although this did not reach statistical
significance, there was a strong trend toward improved sur-
vival (Fig 2, B; P  .075). There were no differences in the
Table II. Univariate analysis of variables tested for associa
Variable No (n 
Age (y) 75.5 
History of COPD 45.0 (
History of CVA 13.3 (
History of CAD 63.3 (
Smoking 40.0 (
Any prior aortic reconstruction 36.7 (
Preoperative characteristics
Symptom onset to OR (h)
6 17.2 (
6-24 34.5 (
24 48.3 (
Mean time 53.9 
Preoperative shock 26.7 (
Preoperative CPR 6.7 (
Aneurysm size and blood chemistry
Aneurysm diameter (cm) 8.1 
Free rupture 16.7 (
Mycotic 3.3 (
BUN 27.7 
Creatinine 1.4 
Hemoglobin 11.3 
Operative characteristics
OR time (h) 4.9 
Excluding intraoperative deaths
OR fluid used 4814 
Blood units used 6.4 
Lowest SBP 78.8 
Operative CPR 3.3 (
Sequential clamping 24.1 (
Clamp time 63.4 
Visceral ischemia time 42.5 
Renal ischemia time 38.8 
Renal cold perfusion 30.0 (
Renal bypass 26.7 (
Intercostal reimplantation 3.3 (
Left heart bypass 46.7 (
CSF drain 70.0 (
Narcan 26.7 (
Outcomes
Dialysis (any) 20.7 (
Tracheostomy 33.3 (
Pneumonia 40.0 (
Paraplegia/paraparesis 13.3 (
Data are % (n) or mean  SD.
COPD, Chronic obstructive pulmonary disease; CVA, cerebrovascular accid
resuscitation; BUN, blood urea nitrogen; SBP, systolic blood pressure; CSFbaseline patient characteristics or preoperative variables (in-cluding preoperative shock and the need for CPR) over time,
whereas there were significant differences in the intraoperative
variables; patients in the latter half of this series had signifi-
cantly fewer blood transfusions (10.4 vs 5.9 units; P .037)
and a shorter period of renal ischemia (53.5 vs 35.2 minutes;
P .043).
DISCUSSION
This study illustrates that repair of RDTAA still poses a
daunting challenge to both the surgeon and the patient. It is a
highly lethal problem with lasting effects. According to one
report, approximately 50% of patients with rupture of a tho-
with in-hospital mortality
In-hospital mortality
P valueYes (n  11)
75.5  6.8 .93
60.0 (6) .30
20.0 (2) .63
80.0 (8) .45
33.3 (3) 1.0
36.7 (4) 1.0
.041
50.0 (5)
40.0 (4)
10.0 (1)
18.7  28.3 .07
70.0 (7) .024
45.4 (5) .01
9.2  3.0 .33
54.5 (6) .041
18.2 (2) .17
23.1  10.3 .66
1.3  0.5 .85
12.8  7.6 .92
3.3  2.4 .08
5.2  1.4 .69
3902  2199 .21
12.7  8.2 .033
50.3  29.6 .007
72.3 (8) .001
25.0 (2) 1.0
76.7  22.3 .28
54.2  12.7 .14
71.2  11.1 .014
80.0 (4) .052
40.0 (2) .61
0 (0) 1.0
22.2 (2) .26
10.0 (1) .002
10.0 (1) .40
0 (0) 1.0
100.0 (1) .35
100.0 (2) .18
50.0 (1) .29
AD, coronary artery disease; OR, operating room; CPR, cardiopulmonary
rospinal fluid.tion
30)
6.6
12)
4)
19)
12)
11)
5)
10)
14)
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8)
2)
1.9
5)
1)
11.1
0.8
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1.2
2275
3.8
13.4
1)
7)
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15.1
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ent; Cracic aortic aneurysm die within 6 hours of the onset of
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hours, thus allowing little time for surgical repair. 11 In this
series, the mortality rate was 26.8%, with most deaths (82%)
occurring within the first 24 hours after operation and well
over half (62%) of late deaths taking place within 4 months of
discharge from hospital, thus reflecting a sustained increased
risk of mortality even after successful repair and hospital dis-
charge. This corroborates the findings of earlier studies that
there is increased age-adjusted mortality throughout the first
postoperative year after repair of both ruptured TAAAs and
abdominal aortic aneurysms.3,12 The overall actuarial survival
at 1 year was 63.6% and at 2 years was 48.5%. For the hospital
survivors, the corresponding figures were 73.3% and 64.4%.
The reason for the high morbidity and mortality is multi-
factorial and clearly more complex than the hemodynamic
instability of the patient at presentation. Previous investiga-
tions have shown that advanced age, female sex, type II
aneurysms, preoperative renal insufficiency, increased aortic
Table III. Factors associated with mortality within the
first 2 years after discharge from the hospital (Cox
proportional hazards methodology)
Variable
Hazard
ratio
95% Confidence
interval P value
COPD 17.68 1.47-213.28 .024
BUN 1.12 1.03-1.21 .005
Extent of repair
(vs type IV)
Type I 1.32 0.10-17.49 .83
Type II 39.28 1.41-1095.27 .031
Type III 101.73 3.62-2856.82 .007
Isolated DTA 3.51 0.55-22.58 .18
COPD, Chronic obstructive pulmonary disease; BUN, blood urea nitrogen;
DTA, descending thoracic aneurysm.
Table IV. Factors associated with increased morbidity
and mortality with logistic regression analysis
Outcome
Odds
ratio
95% Confidence
interval P value
Death
Lowest OR blood pressure 0.9 0.82-0.99 .037
Need for tracheostomy
Increased aneurysm size
(each 1 cm) 5.4 1.12-26.48 .036
COPD 26.0 1.57-431.1 .023
Paraplegia
Extent of aneurysm* .001
Type II vs I 2.0
Type II vs III 1.3
Type II vs IV 2.0
Type II vs isolated DTA 2.0
Clamp time 1.1 1.01-1.16 .03
Dialysis
Increased baseline creatinine 31.2 1.6-591.1 .02
OR,Operating room;COPD, chronic obstructive pulmonary disease;DTA,
descending thoracic aortic aneurysm.
*Analysis of variance.clamp time, preoperative shock, coronary events, and lowhospital and surgeon volume increase the risk of adverse
outcomes after repair of ruptured or emergent repair of DTA
and TAAA.1,3,13-17 Our data confirm that preoperative shock
and type II aneurysm portend an increased incidence of mor-
tality and paraplegia, respectively.
A number of earlier reports are difficult to interpret be-
cause of the heterogeneous nature of their clinical material.
Some included aortic dissections,13,18-21 whereas others in-
corporated symptomatic aneurysms without rupture in their
reviews.15,16 Furthermore, reporting standards for mortality
are not uniform across the literature; some report 30-day
mortality, and others report in-hospital mortality. The results
in this series are within the reported range in the available
literature. In a review of statewide experience, Rigberg et al3
reported a 30-day mortality rate of 48.4%, a finding similar to
the 53.8% rate in a survey of theNationwide Inpatient Sample
reported by Cowan and associates.1 Smaller institutional se-
ries2,13,15-17,19 have reported mortality rates ranging from
15% to 67%. Themid-term survival rates seen in this series are
also in accordance with the findings of earlier reports3,16,22 in
which 1-year mortality rates have been reported between 47%
and 61.5%.
With respect to the effects of age on mortality, a progres-
sive decrease in 1-year survival rates with advanced age, from
44.4% for patients in their 50s to 31.2% for those in their 80s,
has been noted.3 Huynh and colleagues23 reported a 50%
30-day mortality rate for “high-risk” octogenarians present-
ing with rupture, diabetes, or congestive heart failure. In this
regard, the results in this report compare favorably; the 1-year
survival estimate for octogenarians was 50%, and the 2-year
estimate was 37.5%. In our experience, nearly 30% of cases
(12/41)were octogenarians, and theirmortality did not differ
from that of the younger patients. This occurred even though
the octogenarians were more anemic at presentation than the
younger population; it is of note, however, that they also had
a shorter renal ischemic time. Although advanced age has
been found to be a predictor of poor acute and long-term
outcome,1,3,23 our data indicate that age alone is not a major
criterion in the decision-making process of whether to offer
repair of RDTAAs.
Although adjunctive end-organ protection methods have
effectively reduced adverse outcomes in elective settings,24-26
the time constraints encountered in the life-threatening con-
dition of RDTAA dissuade their routine use. Girardi et al17
used CSF drainage in only 50% of their patients and reported
a paraplegia rate of only 5%, similar to their elective data.
LeMaire et al19 failed to demonstrate beneficial effects of left
heart bypass or intercostal artery attachment against the devel-
opment of paraplegia in the absence of CSF drainage. In the
present study, the efficacy of distal aortic perfusion, CSF
drainage, or naloxone could not be demonstrated, largely
because it was not routinely used and because relatively few
patients had events. The incidence rate of spinal cord ischemia
is similar to the rates published in other series of ruptured
TAAAs, which almost universally are significantly higher than
those seen in elective cases.16,27 Given the low numbers and
lack of randomization, the efficacy of adjunctive measures will
likely need to be extrapolated from elective series.
g tho
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April 2007672 Barbato et alAssociationswith outcome andhospital volume are some-
what controversial, because some authors found that hospital
experience did result in an improvement in mortality in the
setting of elective thoracic aneurysm repair.3,28,29 In the
emergent setting, such an association has not been uniformly
observed. Schepens et al22 reported no improvement in mor-
tality with time; Rigberg et al3 found that only low-volume
centers (one case per year) were associated with increased
mortality at 1 year. The observed superior outcome in the
centers of excellence may be in part related to intrinsic factors
related to patient presentation and referral patterns. Crawford
and colleagues’18 original report of 117 ruptured thoracic and
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Fig 2. Kaplan-Meier analysis of survival after descendin
repair. Survival is analyzed according to age at operationthoracoabdominal aneurysmsdescribed anonset of symptomsrelated to rupture of less than 24 hours in only 16% of their
patients, and as many as 34% of patients had symptoms ex-
ceeding 1 week. This may represent a selection or referral bias
favoring outcomes, because our data would suggest that pa-
tients undergoing operation sooner after symptom onset have
the highest mortality. In a report by LeMaire and associates,19
97% of their patients were hemodynamically stable at presen-
tation. This is in contrast to the present series, in which 36.6%
of patients presented with a systolic blood pressure less than
90 mm Hg. We made every effort to accept all patients from
outlying facilities with an intention to repair, unless they were
deemed medically inoperable. This is well reflected by the
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sally in extremis at presentation.
Compromised functional status after urgent/emergent
TAAA repair has been detailed in a report by Rectenwald et
al.16 In that study, a “bad” outcome— defined as nonambu-
latory status, discharge to a long-term care facility, or death—
was noted in 44% of patients surviving to discharge.However,
at 1 year, 87% of patients with follow-up were at home and
ambulatory. Similarly, only 6 of 30 surviving patients in this
series were discharged home, whereas 24 were discharged
either to a skilled nursing facility or to a rehabilitation center.
Only two of these were in a long-term nursing home at last
follow-up, including the lone long-term (3 years) survivor
with paraplegia. Despite the high demand for extended care
even after hospital discharge, repair of RDTAA seems well
justified because it is a uniformly lethal condition without
therapy.
The data in this series strongly suggest the pertinence of
volume regarding outcome. Our volume has increased in
recent years such that the half of our experience was accumu-
lated over the past 3.5 years and has been concentrated on two
surgeons. Although it did not reach significance, owing to
small number of patients, a strong trend toward improved
mortality in the latter part of our experience most likely
represents improved efficiency in the management of these
patients with enhanced surgeon and institutional experience.
This trend was associated with a more conservative approach
to fluid management, with approximately half the intraopera-
tive blood transfusion in the second half of our experience
despite similar degrees of hemodynamic instability and patient
comorbidities. Thus, prompt diagnosis and expeditious inter-
vention or referral to high-volume centers would be desirable
to maximize the chance of optimal outcome.
High incidences of adverse outcomes and laborious, com-
plicated postoperative courses have driven the need for alter-
native methods of repair. With successful application of endo-
vascular technology in the arena of isolated DTA,30 its
horizon is being expanded to include treatment of thoracoab-
dominal and arch lesions using branched graft technology 4-6
and hybrid procedures,7-9 with promising preliminary results.
In a series of 26 TAAAs treated by hybrid procedures, no
paraplegia and a mortality rate of 13% were noted in the 23
elective patients, whereas all 3 patients who presented with
rupture died.7 In another series, an overall mortality rate of
30% and paraplegia rate of 20% were reported; in two patients
who presentedwith rupture, there was one paraplegia with no
death.9 The results with these alternative approaches may
improve with further refinement of technology and skills and
may be applicable to repair of ruptured aneurysms.Until then,
direct surgical repair forRDTAAprovides ameaningfulwayof
saving lives. There is still room for improvement, however,
and concerted efforts need to be made to improve surgical
outcome. Regionalization of this complex aortic surgery to
centers of excellence with high volume should be considered.
This series contributes to contemporary results of open repair
of ruptured thoracic and thoracoabdominal aneurysms and
helps provide a standard against which results of future endo-
vascular endeavors should be held.We thank Faith Selzer, PhD, for her invaluable assis-
tance with statistical analysis.
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Appendix Table I.
Patient, preoperative, and operative characteristics by time from symptom onset in patients undergoing surgery for TAA
and TAAA rupture
Variable
Time from symptom onset
P value*6 h (n10) 6-24 h (n14) 24 h (n15)
Patient characteristics
Age (y) 74.9  7.0 (74.5) 74.6  7.4 (74.0) 76.5  5.7 (78.0) .56
Female 30.0 (3) 28.6 (4) 46.7 (7) .54
White 87.5 (7) 100.0 (14) 93.3 (14) .68
History of COPD 55.6 (5) 64.3 (9) 20.0 (3) .044
History of CVA 11.1 (1) 14.3 (2) 13.3 (2) 1.0
History of CAD 55.6 (5) 71.4 (10) 66.7 (10) .83
Smoking 33.3 (3) 46.1 (6) 40.0 (6) .83
History of diabetes mellitus 11.1 (1) 0 (0) 4.5 (1) .24
Any prior aortic reconstruction 40.0 (4) 57.1 (8) 20.0 (3) .12
Preoperative characteristics
Transportation mode .43
Air 50.0 (5) 78.6 (11) 73.3 (11)
Ground 30.0 (3) 21.4 (3) 20.0 (3)
In-hospital 20.0 (2) 0 (0) 6.7 (1)
Time (h) 3.4  2.0 (4.3) 13.9  6.0 (12.5) 101.4  57.8 (97.0) .001
Preoperative shock 80.0 (8) 28.6 (4) 20.0 (3) .007
Preoperative CPR 50.0 (5) 14.3 (2) 0 (0) .001
Aneurysm size and blood chemistry
AAA diameter (cm)† 7.8  2.4 (7.5) 9.0  2.5 (8.5) 8.3  2.2 (7.7) .31
Contained AAA 60.0 (6) 28.6 (4) 0 (0) .001
Extent .99
Type I 20.0 (2) 21.4 (3) 13.3 (2)
Type II 10.0 (1) 7.1(1) 6.7 (1)
Type III 30.0 (3) 28.6 (4) 20.0 (3)
Type IV 30.0 (3) 28.6 (4) 40.0 (6)
Type VI 10.0 (1) 14.3 (2) 20.0 (3)
Mycotic 20.0 (2) 0 (0) 6.7 (1) .24
BUN (mg/dL) 24.9  12.6 (22.5) 23.5  9.4 (24.5) 25.9  11.4 (23.0) .90
Creatinine (mg/dL) 1.6  1.1 (1.3) 1.3  0.6 (1.1) 1.3  0.6 (1.1) .70
Hemoglobin (g/dL) 13.2  8.1 (10.5) 11.9  2.4 (12.5) 10.7  2.5 (10.6) .27
Hematocrit (%) 29.2  7.3 (30.3) 34.7  6.5 (36.2) 32.5  7.3 (32.4) .13
Operative characteristics
After 2002 50.0 (5) 42.9 (6) 66.7 (10) .42
OR time (h) 3.7  2.5 (4.8) 4.5  1.6 (4.4) 4.7  1.2 (4.7) .84
OR fluid used 4200  1949 (3750) 5080  2710 (4200) 4157  1750 (4100) .72
Blood units used 9.1  6.0 (7.0) 8.1  7.3 (5.5) 6.9  4.2 (6.0) .51
Lowest SBP (mm Hg)† 63.9  34.8 (79.0) 68.6  19.3 (72.0) 82.5  5.6 (80.0) .032
Operative CRP 50.0 (5) 21.4 (3) 0 (0) .007
Sequential clamp use 37.5 (3) 8.3 (1) 26.7 (4) .30
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Variable
Time from symptom onset
P value*6 h (n10) 6-24 h (n14) 24 h (n15)
Clamp time (min)† 62.3  9.8 (59.0) 63.0  15.6 (64.5) 65.5  24.3 (56.0) .96
Visceral ischemia time (min)† 43.7  12.6 (44.0) 44.7  19.4 (45.0) 41.9  9.9 (40.0) .79
Renal ischemia time (min)† 47.2  13.7 (50.0) 46.1  26.6 (47.5) 36.6  23.2 (35.0) .39
Renal perfusion† 16.7 (1) 33.3 (4) 40.0 (6) .42
Renal bypass† 33.3 (2) 16.7 (2) 40.0 (6) .42
Intercostal reimplantation† 0 (0) 0 (0) 6.7 (1) 1.0
LHB† 50.0 (4) 28.6 (4) 40.0 (6) .57
CSF drain† 44.4 (4) 50.0 (7) 66.7 (10) .54
Naloxone† 22.2 (2) 14.3 (2) 33.3 (5) .56
Data are % (n) or mean  SD (median).
AAA, Abdominal aortic aneurysm; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; CAD, coronary artery disease; CPR,
cardiopulmonary resuscitation; BUN, blood urea nitrogen; OR, operating room; SBP, systolic blood pressure; CRP, C-reactive protein; CSF, cerebrospinal
fluid.
*Compared by using the Fisher exact test (categorical variables) or Kruskal-Wallis test (continuous variables).
†The sample size for each is as follows (the time from symptom onset to OR was unknown for two patients):
Race, LHB, and lowest systolic blood pressure, n 8 (6 h), n 14 (6-24 h), n 15 (24 h)
Smoking: n 9 (6 h), n 13 (6-24 h), n 15 (24 h)
COPD, CVA, CAD, diabetes mellitus, naloxone, CSF drain: n  9 (6 h), n  14 (6-24 h), n  15 (24 h)
Renal perfusion, renal bypass, intercostal implantation: n  6 (6 h), n  12 (6-24 h), n  15 (24 h)
Dialysis: n  5 (6 h), n  11 (6-24 h), n  15 (24 h)
Tracheostomy: n  6 (6 h), n  10 (6-24 h), n  14 (24 h)
Sequential clamp: n  8 (6 h), n  12 (6-24 h), n  15 (24 h)
Pneumonia, paraplegia, paraparesis: n  6 (6 h), n  11 (6-24 h), n  14 (24 h)
AAA diameter: n  8 (6 h), n  13 (6-24 h), n  12 (24 h)
Clamp time: n  6 (6 h), n  10 (6-24 h), n  14 (24 h)
Visceral ischemia time: n  6 (6 h), n  12 (6-24 h), n  13 (24 h)Appendix Table II.
Outcome characteristics by time from symptom onset in patients undergoing repair of ruptured TAA and TAAA
Variable
Time from symptom onset
P value*6 h (n  10) 6-24 h (n  14) 24 h (n  15)
Outcomes
Dialysis (any)† 20.0 (1) 36.4 (4) 7.1 (1) 0.22
Tracheostomy† 33.3 (2) 50.0 (5) 28.6 (4) 0.62
Pneumonia† 50.0 (3) 54.5 (6) 35.7 (5) 0.64
Paraplegia (any)† 16.7 (1) 9.1 (1) 21.4 (3) 0.82
Paraparesis (any)† 16.7 (1) 9.1 (1) 21.4 (3) 0.82
In-hospital death 50.0 (5) 28.6 (4) 6.7 (1) 0.041
Length of stay (discharged only) 18.8  17.3 (11.0) 22.3  18.6 (15.0) 14.6  9.6 (11.5) 0.70
Days to in-hospital death 6.2  13.9 (0) 1.7  3.5 (0) 0 (0) 0.88
Data are % (n) or mean  SD (median).
LHB, left heart bypass.
*Compared by using the Fisher exact test (categorical variables) or Kruskal-Wallis test (continuous variables).
†The sample size for each is as follows (the time from symptom onset to operating room was unknown for two patients):
Race, LHB, and lowest systolic blood pressure: n  8 (6 h), n  14 (6-24 h), n  15 (24 h)
Smoking: n  9 (6 h), n  13 (6-24 h), n  15 (24 h)
Chronic obstructive pulmonary disease, cerebrovascular accident, coronary artery disease, diabetes mellitus, naloxone, cerebrospinal fluid drain: n 9 (6 h),
n  14 (6-24 h), n  15 (24 h)
Renal perfusion, renal bypass, intercostal implantation: n  6 (6 h), n  12 (6-24 h), n  15 (24 h)
Dialysis: n  5 (6 h), n  11 (6-24 h), n  15 (24 h)
Tracheostomy: n  6 (6 h), n  10 (6-24 h), n  14 (24 h)
Sequential clamp: n  8 (6 h), n  12 (6-24 h), n  15 (24 h)
Pneumonia, paraplegia, paraparesis: n  6 (6 h), n  11 (6-24 h), n  14 (24 h)
Abdominal aortic aneurysm diameter: n  8 (6 h), n  13 (6-24 h), n  12 (24 h)
Clamp time: n  6 (6 h), n  10 (6-24 h), n  14 (24 h)
Visceral ischemia time: n  6 (6 h), n  12 (6-24 h), n  13 (24 h)
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Dr Michael J. Singh (Rochester, NY). Dr Cho and his
colleagues have addressed several important issues in the manage-
ment of ruptured thoracoabdominal aortic aneurysms. Your study
has cleared the air and provided a benchmark for direct open repair
of nondissected ruptured thoracoabdominal aneurysms. The ma-
jority of previously published reports failed to separate aortic
dissections from degenerative aneurysms. The authors have ana-
lyzed the outcomes, risk factors, and natural history of a select
group of patients over an 8-year period.
Contemporary series have reported an elective mortality rate
of 6% to 19% for open repair and a repair-free survival of 52% at 2
years. I was pleasantly surprised to learn that your operative mor-
tality rate for a rupture was 26% and the 2-year survival was nearly
50%. Even more interesting is your Kaplan-Meier survival analysis
that shows there is no significant difference in survival between
octogenarians and those who are younger.
In review of your manuscript, I noticed that four of your 40
patients were inpatients at the time of rupture, fully 10%. This
seems unusual. Was the timing of their rupture coincidental, or
were the patients being observed for their aneurysms in-house?
Were their outcomes improved by a presumed earlier diagnosis and
expeditious operative procedure? Could you provide some addi-
tional information of the instituted changes that your group has
made to improve your outcomes in the latter part of your series and
has this trend continued?
Endovascular stent grafts have reduced mortality and compli-
cation rates in traumatic aortic injuries and ruptured aortic aneu-
rysms; however, I am hesitant to imagine that ruptured thoraco-
abdominal aneurysms will have an improved outcome with an
emergent fenestrated endovascular repair. At your institution, have
you had any experience with an endovascular repair for this cata-
strophic problem? As endovascular techniques evolve, I suspect
that many endovascular experts will reference this article for future
comparison.
Dr Joel Barbato. Thank you very much for your comments.
As far as your first question referring to those patients who rup-tured while in the hospital setting, what I can tell you is that all of
them were evaluated for rupture. They all had preoperative or
in-hospital CT scans, or were referred from other hospitals with
CT scans that failed to demonstrate a rupture. As far as whether this
is unusual, I can’t speak to that. And I don’t think we broke down
the outcomes in those particular patients who ruptured within the
hospital. As I mentioned, those patients with a shorter duration
from symptom onset to OR actually had worse outcomes, and
that’s likely a selection bias.
As far as changes in practice at our institution, obviously none
of the factors that I showed up on the screen had a significant
impact in terms of mortality. One of the things that has been
instituted recently is an increased use of Narcan, one of the
particular surgeons uses that, although that wasn’t associated with
reduction in mortality.
The other institutional change is that whereas a total of four
surgeons performed the operations in the first half of the series,
only two surgeons have been performing this operation since 2003
at our institution. And I think what we do see here is that with
increasing surgeon and institutional experience, the outcomes, for
whatever reason, seemed to be improved.
As far as the endovascular repair, the short answer is we have
not used either a hybrid or a fenestrated graft for the repair,
particularly in this setting, although we have used them for isolated
descending thoracic aortic aneurysms, both in the traumatic set-
ting as well as in the degenerative ruptured setting.
There are only two studies that I am aware of that actually exist
in the literature that describe these hybrid technologies in the
setting of emergent or rupture. In one of these studies, all three of
the patients that had utilization of this hybrid technology died in
the postprocedure period. So I think your comment is a good one,
that there certainly is a steep learning curve to these complex
technologies. And I think the applications, at least initially here, are
going to be somewhat limited.
